For more than twenty years, the Drug Policy Research Group (DPRG) has generated many important studies that have advanced our understanding of how pharmaceutical policies affect patient health in the U.S. and abroad.  Over the years, the strength of DPRG’s research, methods, mentorship, and people have attracted faculty and staff with interest in pharmaceutical and other types of health policies, but with the same underlying passion to generate the most robust evidence to inform policies and health systems.  The change in name to the Division of Health Policy and Insurance Research encompasses this broader scope of work.  Please visit HPI to learn more about current research, training, and policy activities.